ClinicalTrials.Veeva

Menu

The Effect of Parecoxib Sodium Intravenous Patient-controlled Analgesia in Laparotomic Liver Resection

H

Harbin Medical University

Status

Unknown

Conditions

Pain, Postoperative

Treatments

Procedure: intravenous infusion pump of patient-controlled analgesia
Drug: fentanyl citrate+ ondansetron hydrochloride + normal saline
Procedure: conventional intravenous infusion pump
Drug: parecoxib
Drug: celecoxib

Study type

Interventional

Funder types

Other

Identifiers

NCT02408146
Lianxin-001

Details and patient eligibility

About

The investigators hypothesized that using new intravenous infusion pump of patient-controlled analgesia (parecoxib sodium 1 mg/mL + normal saline) would significantly improve postoperative pain control compare to conventional intravenous infusion pump of patient-controlled analgesia (fentanyl citrate 20 mg/mL/kg + ondansetron hydrochloride 16 mg/8 mL + normal saline). This prospective randomized controlled trial was designed to evaluate the benefit of new intravenous infusion pump of patient-controlled analgesia (parecoxib sodium 1 mg/mL + normal saline) for postoperative analgesia after laparotomic liver resection.

Enrollment

80 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Patients need laparotomic liver resection.

Exclusion criteria

Patients with contraindications to spinal anesthesia or intrathecal morphine, difficulty understanding passive cutaneous anaphylaxis, a history of drug dependence or chronic pain, body mass index greater than 35 kg/m2, or history of sleep apnea were excluded from this study.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

80 participants in 3 patient groups

conventional intravenous infusion pump
Experimental group
Description:
The first group receives conventional intravenous infusion pump of patient-controlled analgesia.
Treatment:
Drug: fentanyl citrate+ ondansetron hydrochloride + normal saline
Procedure: conventional intravenous infusion pump
parecoxib
Experimental group
Description:
The second group has oral celecoxib before surgery, then receives parecoxib sodium intravenously guttae after surgery.
Treatment:
Drug: parecoxib
Drug: celecoxib
new intravenous infusion pump
Experimental group
Description:
The third group uses new intravenous infusion pump of patient-controlled analgesia after surgery.
Treatment:
Drug: parecoxib
Drug: celecoxib
Procedure: intravenous infusion pump of patient-controlled analgesia

Trial contacts and locations

1

Loading...

Central trial contact

Jiabei Wang, PhD; Lianxin Liu, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems